Alnylam Pharmaceuticals
ALNY
#646
Rank
โ‚น3.694 T
Marketcap
โ‚น27,671
Share price
-0.30%
Change (1 day)
0.33%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: โ‚น3.694 Trillion

As of June 2026 Alnylam Pharmaceuticals has a market cap of โ‚น3.694 Trillion. This makes Alnylam Pharmaceuticals the world's 646th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น3.694 T-22.24%
2025โ‚น4.750 T80.43%
2024โ‚น2.633 T31.68%
2023โ‚น1.999 T-17.35%
2022โ‚น2.419 T60.27%
2021โ‚น1.509 T36.7%
2020โ‚น1.104 T19.85%
2019โ‚น921.38 B78.63%
2018โ‚น515.80 B-35.88%
2017โ‚น804.49 B268.48%
2016โ‚น218.33 B-58.99%
2015โ‚น532.33 B12.16%
2014โ‚น474.61 B87.44%
2013โ‚น253.21 B382.76%
2012โ‚น52.45 B184.73%
2011โ‚น18.42 B-1.54%
2010โ‚น18.70 B-45.3%
2009โ‚น34.20 B-30.52%
2008โ‚น49.22 B5.79%
2007โ‚น46.53 B32.51%
2006โ‚น35.11 B202.91%
2005โ‚น11.59 B85.84%
2004โ‚น6.23 B

End of Day market cap according to different sources

On Jun 25th, 2026 the market cap of Alnylam Pharmaceuticals was reported to be:

โ‚น3.694 Trillion
by Nasdaq info icon info icon
โ‚น3.694 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
โ‚น27.936 T 656.18%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚น9.444 T 155.63%๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
โ‚น6.136 T 66.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น159.63 B-95.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
โ‚น53.32 B-98.56%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚น107.61 B-97.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น3.694 T 0.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
โ‚น1.053 T-71.47%๐Ÿ‡บ๐Ÿ‡ธ USA